If this miRNA also targets SMAD2 in TM cells, this may contribute to the increased ECM remodeling observed in glaucoma patients e.g. increase production of fibronectin that leads to increased stiffness and reduced AH outflow.60 The gene discussed is SMAD2; the disease is glaucoma.